Informazioni generali
  • Categoria della malattia Malattie del sistema nervoso (BASEC)
  • Stato di reclutamento reclutamento in corso (BASEC/ICTRP)
  • Luogo dello studio
    Losanna
    (BASEC)
  • Responsabile dello studio Prof. Grégoire Courtine gregoire.courtine@epfl.ch (BASEC)
  • Fonte dati BASEC: Importato da 16.04.2025 ICTRP: N/A
  • Ultimo aggiornamento 16.04.2025 15:15
HumRes63013 | SNCTP000005611 | BASEC2023-D0033

Study on the preliminary safety and efficacy of ARC Therapy using the ARC-IM Lumbar System to support the mobility of individuals with a chronic spinal cord injury (BoxSwitch)

  • Categoria della malattia Malattie del sistema nervoso (BASEC)
  • Stato di reclutamento reclutamento in corso (BASEC/ICTRP)
  • Luogo dello studio
    Losanna
    (BASEC)
  • Responsabile dello studio Prof. Grégoire Courtine gregoire.courtine@epfl.ch (BASEC)
  • Fonte dati BASEC: Importato da 16.04.2025 ICTRP: N/A
  • Ultimo aggiornamento 16.04.2025 15:15

Descrizione riassuntiva dello studio

This study aims to evaluate the preliminary safety and efficacy of ARC Therapy, which uses an implantable spinal cord electrical stimulation system, with the goal of promoting mobility and potentially improving other clinical functions such as spasticity following a chronic spinal cord injury. The study will assess the safety of using the system and associated procedures to properly integrate it into standard clinical rehabilitation programs. It will also evaluate the safety and efficacy of the therapy in the short and long term on mobility, spasticity, bowel, urinary, and sexual functions, as well as quality of life.

(BASEC)

Intervento studiato

In this study, participants who have completed the STIMO study protocol (SNCTP000001953) will be offered to replace their currently implanted Activa RC stimulator with the ARC-IM IPG to demonstrate that the expanded set of stimulation capabilities can be integrated into the personalization of the SCS protocols. The aim is to improve the efficiency of lower limb motor activities while simplifying the personal use of the system at home. Additionally, under certain conditions (current status of implanted devices, technical and surgical compatibility) and evaluated on a case-by-case basis, this study provides for a strategy to replace the stimulation lead.

(BASEC)

Malattie studiate

Spinal cord injury

(BASEC)

Criteri di partecipazione
- Completion of the main phase of the STIMO study (NCT02936453) and improvement in at least one of the primary or secondary evaluation criteria (WISCI II score, 10-meter walk test (10MWT), weight-bearing capacity test (Weight Bearing Capacity), SCIM III score, or 6-minute walk test (6MWT)) - Age 18-65 years - Spinal cord injury classified according to the AIS scale (American Spinal Injury Association Impairment Scale) A, B, C, and D. - Spinal cord injury older than 12 months - Spinal cord injury above T10, with preservation of conus functions - Spinal cord injury caused by trauma - Stable physical and psychological medical condition as assessed by investigators - Able to understand and interact in French or English with the study team - Agrees to comply in good faith with all study conditions and to attend all scheduled appointments - Must provide and sign informed consent prior to any study-related procedure (BASEC)

Criteri di esclusione
- Diseases and conditions that would increase morbidity and mortality of spinal cord injury surgery - History of myocardial infarction or stroke within the last 6 months - Limitation of walking function due to accompanying disorders (CNS) (systemic malignant diseases, cardiovascular disorders limiting physical training, peripheral nerve disorders) - Any active implanted cardiac device, such as a pacemaker or defibrillator - Any indication requiring diathermy - Any indication requiring MRI - Any anatomical limitation in the implantation area at the discretion of the investigators - Other conditions that would render the subject unable to participate in the tests at the discretion of the investigators - Clinically significant mental illness at the discretion of the investigators - Presence of an intrathecal baclofen pump or insulin pump - Other clinically significant concomitant pathological states (e.g., renal failure, liver dysfunction, cardiovascular disease, etc.) - Inability to follow study procedures, e.g., due to language issues, psychological disorders, or participant dementia - Inclusion of the investigator, family members, employees, and other dependents - Pregnant women (pregnancy test mandatory for women of childbearing age) or breastfeeding women (BASEC)

Luogo dello studio

Losanna

(BASEC)

non disponibile

Sponsor

-

(BASEC)

Contatto per ulteriori informazioni sullo studio

Persona di contatto in Svizzera

Prof. Grégoire Courtine

+41 21 69 30762

gregoire.courtine@epfl.ch

EPFL

(BASEC)

Informazioni scientifiche

non disponibile

Nome del comitato etico approvante (per studi multicentrici solo il comitato principale)

Commissione d'etica Vaud

(BASEC)

Data di approvazione del comitato etico

24.08.2023

(BASEC)


ID di studio ICTRP
non disponibile

Titolo ufficiale (approvato dal comitato etico)
Study on preliminary safety and efficacy of the ARC Therapy using the ARC-IM Lumbar System to support mobility in people with chronic spinal cord injury (BASEC)

Titolo accademico
non disponibile

Titolo pubblico
non disponibile

Malattie studiate
non disponibile

Intervento studiato
non disponibile

Tipo di studio
non disponibile

Disegno dello studio
non disponibile

Criteri di inclusione/esclusione
non disponibile

non disponibile

Endpoint primari e secondari
non disponibile

non disponibile

Data di registrazione
non disponibile

Inclusione del primo partecipante
non disponibile

Sponsor secondari
non disponibile

Contatti aggiuntivi
non disponibile

ID secondari
non disponibile

Risultati-Dati individuali dei partecipanti
non disponibile

Ulteriori informazioni sullo studio
non disponibile

Risultati dello studio

Riepilogo dei risultati

non disponibile

Link ai risultati nel registro primario

non disponibile